Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men

NCT00467870 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

531

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism
Primary Hypogonadism
Secondary Hypogonadism

Interventions

DRUG: Testosterone Undecanoate 750 mg
DRUG: Testosterone Undecanoate 1000 mg

Sponsor

Endo Pharmaceuticals